- Home
- IPA vs FLGC Comparison
IPA vs FLGC Comparison
Compare IPA & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPA
- FLGC
- Stock Information
- Founded
- IPA 1983
- FLGC 2019
- Country
- IPA United States
- FLGC United States
- Employees
- IPA N/A
- FLGC N/A
- Industry
- IPA Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- IPA Health Care
- FLGC Health Care
- Exchange
- IPA Nasdaq
- FLGC Nasdaq
- Market Cap
- IPA 19.3M
- FLGC 17.3M
- IPO Year
- IPA 2017
- FLGC 2021
- Fundamental
- Price
- IPA $0.44
- FLGC $0.54
- Analyst Decision
- IPA Strong Buy
- FLGC Strong Buy
- Analyst Count
- IPA 2
- FLGC 3
- Target Price
- IPA $4.00
- FLGC $5.00
- AVG Volume (30 Days)
- IPA 471.7K
- FLGC 177.6K
- Earning Date
- IPA 03-28-2025
- FLGC 05-13-2025
- Dividend Yield
- IPA N/A
- FLGC N/A
- EPS Growth
- IPA N/A
- FLGC N/A
- EPS
- IPA N/A
- FLGC N/A
- Revenue
- IPA $16,581,105.00
- FLGC $59,505,000.00
- Revenue This Year
- IPA $4.67
- FLGC $4.28
- Revenue Next Year
- IPA $14.15
- FLGC N/A
- P/E Ratio
- IPA N/A
- FLGC N/A
- Revenue Growth
- IPA 1.34
- FLGC N/A
- 52 Week Low
- IPA $0.27
- FLGC $0.42
- 52 Week High
- IPA $1.39
- FLGC $2.11
- Technical
- Relative Strength Index (RSI)
- IPA 54.99
- FLGC 44.16
- Support Level
- IPA $0.36
- FLGC $0.44
- Resistance Level
- IPA $0.48
- FLGC $0.52
- Average True Range (ATR)
- IPA 0.05
- FLGC 0.06
- MACD
- IPA 0.01
- FLGC 0.01
- Stochastic Oscillator
- IPA 74.85
- FLGC 51.97
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.